BETAFERON Side Effects

6926426-X | Gestational Hypertension, No Adverse Event
on Aug 09, 2010 Female patient from BRAZIL , 37 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Betaferon (View Usage). Patient experienced the following unwanted or unexpected effects: gestational hypertension, no adverse event. Betaferon dosage: . Patient was hospitalized.

6926425-8 | Skin Necrosis
Patient was taking Betaferon (View Usage). Patient had the following side effects: skin necrosis on Aug 03, 2010 from JAPAN Additional patient health information: Female patient , 50 years of age, . Betaferon dosage: .

6923741-0 | Adverse Event, Food Poisoning, Injection Site Haematoma, Injection Site Reaction, Mobility Decreased
Adverse event was reported on Jul 21, 2010 by a Male patient taking Betaferon (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED KINGDOM , 56 years of age, After Betaferon was administered, patient had the following side effects: adverse event, food poisoning, injection site haematoma, injection site reaction, mobility decreased. Patient was hospitalized and became disabled.

6923739-2 | Muscular Weakness
on Jul 21, 2010 Female patient from TAIWAN, PROVINCE OF CHINA , 42 years of age, weighting 123.5 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Betaferon (View Usage). Patient experienced the following unwanted or unexpected effects: muscular weakness. Betaferon dosage: . Patient was hospitalized.


6923737-9 | Fall, Head Injury
on Jul 28, 2010 Female patient from AUSTRALIA , 72 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?), cystitis and was treated with Betaferon (View Usage). Patient had the following side effects: fall (What is fall?), head injury. Betaferon dosage: . During the same period patient was treated with CYMBALTA (View Cymbalta Review and Cymbalta Label ), DITROPAN (View Ditropan Review and Ditropan Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), EPILEM (View Epilem Review and Epilem Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6923736-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Hepatic Steatosis
Patient was taking Betaferon (View Usage). After Betaferon was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, hepatic steatosis on Jul 22, 2010 from SWEDEN Additional patient health information: Female patient , 50 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Betaferon dosage: .

6923734-3 | Abasia, Coordination Abnormal, Influenza Like Illness, Injection Site Haematoma, Pyrexia
Adverse event was reported on Jul 25, 2010 by a Male patient taking Betaferon (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED KINGDOM , 57 years of age, Patient experienced the following unwanted or unexpected effects: abasia, coordination abnormal, influenza like illness, injection site haematoma, pyrexia.

6923733-1 | Dizziness, Unevaluable Event, Vomiting
on Jul 28, 2010 Female patient from HONG KONG , 63 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Betaferon (View Usage). Patient had the following side effects: dizziness (What is dizziness?), unevaluable event, vomiting. Betaferon dosage: . Patient was hospitalized.

6923731-8 | Menorrhagia, Menstrual Disorder
on Aug 01, 2010 Female patient from RUSSIAN FEDERATION , 34 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Betaferon (View Usage). After Betaferon was administered, patient had the following side effects: menorrhagia, menstrual disorder. Betaferon dosage: . Patient was hospitalized.

6923725-2 | Burning Sensation, Eye Pain, Face Injury, Fall, Gait Disturbance, Headache, Malaise, Muscle Spasticity, Muscular Weakness
Patient was taking Betaferon (View Usage). Patient experienced the following unwanted or unexpected effects: burning sensation, eye pain, face injury, fall (What is fall?), gait disturbance, headache (What is headache?), malaise, muscle spasticity, muscular weakness on Jul 27, 2010 from BRAZIL Additional patient health information: Male patient , 33 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?), headache (What is headache?) and. Betaferon dosage: Betaject. During the same period patient was treated with AZATHIOPRINE (1 Tab A Day) (View Azathioprine Review and Azathioprine Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6923722-7 | Acute Hepatic Failure, Diabetes Mellitus, Encephalopathy, Jaundice, Nausea
Adverse event was reported on Jul 29, 2010 by a Female patient taking Betaferon (View Usage) (Dosage: ) was diagnosed with contraception, influenza like illness, otitis media, neuropathy peripheral and. Location: AUSTRALIA , 32 years of age, weighting 154.3 lb, Patient had the following side effects: acute hepatic failure, diabetes mellitus, encephalopathy, jaundice (What is jaundice?), nausea (What is nausea?). During the same period patient was treated with LEVELEN ED (View Levelen-ed Review and Levelen-ed Label ), PANADOL (View Panadol Review and Panadol Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ). Patient was hospitalized.

6922474-4 | Abasia, Anaemia, Asthenia, Bedridden, Gait Disturbance, Multiple Sclerosis, Multiple Sclerosis Relapse, Musculoskeletal Stiffness, Speech Disorder
on Jul 30, 2010 Female patient from BRAZIL , 41 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?), muscle spasms, urinary incontinence (What is urinary incontinence?) and was treated with Betaferon (View Usage). After Betaferon was administered, patient had the following side effects: abasia, anaemia, asthenia, bedridden, gait disturbance, multiple sclerosis (What is multiple sclerosis?), multiple sclerosis relapse, musculoskeletal stiffness, speech disorder. Betaferon dosage: Betaject. During the same period patient was treated with BACLOFEN (View Baclofen Review and Baclofen Label ), BUPROVIT (Total Daily Dose: 1200 Mg) (View Buprovit Review and Buprovit Label ), RETEMIC (View Retemic Review and Retemic Label ).

6922473-2 | Amnesia, Aphasia, Asthenia, Blood Calcium Decreased, Blood Magnesium Decreased, Blood Potassium Decreased, Blood Sodium Decreased, Brain Injury
on Aug 04, 2010 Male patient from BRAZIL , 42 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?), mass and was treated with Betaferon (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, aphasia (What is aphasia?), asthenia, blood calcium decreased, blood magnesium decreased, blood potassium decreased, blood sodium decreased, brain injury. Betaferon dosage: Betaject. During the same period patient was treated with SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ). Patient was hospitalized and became disabled.

6922344-1 | Abasia, Blood Cholesterol Increased, Choking, Diplopia, Gait Disturbance, Injection Site Haematoma, Injection Site Pain, Memory Impairment, Mobility Decreased
Patient was taking Betaferon (View Usage). Patient had the following side effects: abasia, blood cholesterol increased, choking (What is choking?), diplopia, gait disturbance, injection site haematoma, injection site pain, memory impairment, mobility decreased on Jul 30, 2010 from BRAZIL Additional patient health information: Female patient , 46 years of age, was diagnosed with relapsing-remitting multiple sclerosis, choking (What is choking?), constipation (What is constipation?), fatigue, abdominal pain upper, urinary incontinence (What is urinary incontinence?), depression (What is depression?) and. Betaferon dosage: Betaject. During the same period patient was treated with TEGRETOL (Total Daily Dose: 800 Mg Unit Dose: 200 Mg) (View Tegretol Review and Tegretol Label ), LACTULONA (As Used: 20 Ml) (View Lactulona Review and Lactulona Label ), AMANTADINE HCL (Total Daily Dose: 200 Mg Unit Dose: 100 Mg) (View Amantadine Hcl Review and Amantadine Hcl Label ), OMEPRAZOLE (Total Daily Dose: 20 Mg Unit Dose: 20 Mg) (View Omeprazole Review and Omeprazole Label ), DOXAZOSIN (Total Daily Dose: 4 Mg Unit Dose: 2 Mg) (View Doxazosin Review and Doxazosin Label ), OXYBUTYNIN (Total Daily Dose: 5 Mg Unit Dose: 5 Mg) (View Oxybutynin Review and Oxybutynin Label ), FLUOXETINE (Total Daily Dose: 20 Mg Unit Dose: 20 Mg) (View Fluoxetine Review and Fluoxetine Label ). Patient was hospitalized and became disabled.

6922343-X | Balance Disorder, Chills, Fatigue, Gait Disturbance, Headache, Injection Site Discolouration, Injection Site Rash, Multiple Sclerosis, Muscular Weakness
Adverse event was reported on Jul 30, 2010 by a Female patient taking Betaferon (View Usage) (Dosage: ) was diagnosed with relapsing-remitting multiple sclerosis, headache (What is headache?), chills and. Location: BRAZIL , 45 years of age, After Betaferon was administered, patient had the following side effects: balance disorder, chills, fatigue, gait disturbance, headache (What is headache?), injection site discolouration, injection site rash, multiple sclerosis (What is multiple sclerosis?), muscular weakness. During the same period patient was treated with LEXAPRO (Half A Day) (View Lexapro Review and Lexapro Label ), NEOSALDINA (View Neosaldina Review and Neosaldina Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6919575-3 | Abasia, Blood Cholesterol Increased, Choking, Diplopia, Gait Disturbance, Injection Site Haematoma, Injection Site Pain, Memory Impairment, Mobility Decreased
on Jul 30, 2010 Female patient from BRAZIL , 46 years of age, was diagnosed with relapsing-remitting multiple sclerosis, choking (What is choking?), constipation (What is constipation?), fatigue, abdominal pain upper, urinary incontinence (What is urinary incontinence?), depression (What is depression?) and was treated with Betaferon (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, blood cholesterol increased, choking (What is choking?), diplopia, gait disturbance, injection site haematoma, injection site pain, memory impairment, mobility decreased. Betaferon dosage: Betaject. During the same period patient was treated with TEGRETOL (Total Daily Dose: 800 Mg Unit Dose: 200 Mg) (View Tegretol Review and Tegretol Label ), LACTULONA (As Used: 20 Ml) (View Lactulona Review and Lactulona Label ), AMANTADINE HCL (Total Daily Dose: 200 Mg Unit Dose: 100 Mg) (View Amantadine Hcl Review and Amantadine Hcl Label ), OMEPRAZOLE (Total Daily Dose: 20 Mg Unit Dose: 20 Mg) (View Omeprazole Review and Omeprazole Label ), DOXAZOSIN (Total Daily Dose: 4 Mg Unit Dose: 2 Mg) (View Doxazosin Review and Doxazosin Label ), OXYBUTYNIN (Total Daily Dose: 5 Mg Unit Dose: 5 Mg) (View Oxybutynin Review and Oxybutynin Label ), FLUOXETINE (Total Daily Dose: 20 Mg Unit Dose: 20 Mg) (View Fluoxetine Review and Fluoxetine Label ). Patient was hospitalized and became disabled.

6919574-1 | Balance Disorder, Chills, Fatigue, Gait Disturbance, Headache, Injection Site Discolouration, Injection Site Rash, Multiple Sclerosis, Muscular Weakness
on Jul 30, 2010 Female patient from BRAZIL , 45 years of age, was diagnosed with relapsing-remitting multiple sclerosis, headache (What is headache?), chills and was treated with Betaferon (View Usage). Patient had the following side effects: balance disorder, chills, fatigue, gait disturbance, headache (What is headache?), injection site discolouration, injection site rash, multiple sclerosis (What is multiple sclerosis?), muscular weakness. Betaferon dosage: . During the same period patient was treated with LEXAPRO (Half A Day) (View Lexapro Review and Lexapro Label ), NEOSALDINA (View Neosaldina Review and Neosaldina Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6918993-7 | Abasia, Anaemia, Asthenia, Bedridden, Gait Disturbance, Multiple Sclerosis, Multiple Sclerosis Relapse, Musculoskeletal Stiffness, Speech Disorder
Patient was taking Betaferon (View Usage). After Betaferon was administered, patient had the following side effects: abasia, anaemia, asthenia, bedridden, gait disturbance, multiple sclerosis (What is multiple sclerosis?), multiple sclerosis relapse, musculoskeletal stiffness, speech disorder on Jul 30, 2010 from BRAZIL Additional patient health information: Female patient , 41 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?), muscle spasms, urinary incontinence (What is urinary incontinence?) and. Betaferon dosage: Betaject. During the same period patient was treated with BACLOFEN (View Baclofen Review and Baclofen Label ), BUPROVIT (Total Daily Dose: 1200 Mg) (View Buprovit Review and Buprovit Label ), RETEMIC (View Retemic Review and Retemic Label ).

6917615-9 | Acute Hepatic Failure, Diabetes Mellitus, Encephalopathy, Jaundice, Nausea
Adverse event was reported on Jul 29, 2010 by a Female patient taking Betaferon (View Usage) (Dosage: ) was diagnosed with contraception, influenza like illness, otitis media, neuropathy peripheral and. Location: AUSTRALIA , 32 years of age, weighting 154.3 lb, Patient experienced the following unwanted or unexpected effects: acute hepatic failure, diabetes mellitus, encephalopathy, jaundice (What is jaundice?), nausea (What is nausea?). During the same period patient was treated with LEVELEN ED (View Levelen-ed Review and Levelen-ed Label ), PANADOL (View Panadol Review and Panadol Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ). Patient was hospitalized.

6915049-4 | Dizziness, Unevaluable Event, Vomiting
on Jul 28, 2010 Female patient from HONG KONG , 63 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Betaferon (View Usage). Patient had the following side effects: dizziness (What is dizziness?), unevaluable event, vomiting. Betaferon dosage: . Patient was hospitalized.

6913214-3 | Fall, Head Injury
on Jul 28, 2010 Female patient from AUSTRALIA , 72 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?), cystitis and was treated with Betaferon (View Usage). After Betaferon was administered, patient had the following side effects: fall (What is fall?), head injury. Betaferon dosage: . During the same period patient was treated with CYMBALTA (View Cymbalta Review and Cymbalta Label ), DITROPAN (View Ditropan Review and Ditropan Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), EPILEM (View Epilem Review and Epilem Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6911742-8 | Abasia, Coordination Abnormal, Dysstasia, Influenza Like Illness, Injection Site Haematoma, Pyrexia
Patient was taking Betaferon (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, coordination abnormal, dysstasia, influenza like illness, injection site haematoma, pyrexia on Jul 25, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 57 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Betaferon dosage: .

6910685-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Hepatic Steatosis
Adverse event was reported on Jul 22, 2010 by a Female patient taking Betaferon (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: SWEDEN , 50 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, hepatic steatosis.

6910652-X | Balance Disorder, Chills, Depression, Headache, Motor Dysfunction, Multiple Sclerosis, Multiple Sclerosis Relapse, Muscle Spasms
on Aug 03, 2010 Male patient from BRAZIL , 42 years of age, was diagnosed with relapsing-remitting multiple sclerosis, bipolar disorder (What is bipolar disorder?) and was treated with Betaferon (View Usage). After Betaferon was administered, patient had the following side effects: balance disorder, chills, depression (What is depression?), headache (What is headache?), motor dysfunction, multiple sclerosis (What is multiple sclerosis?), multiple sclerosis relapse, muscle spasms. Betaferon dosage: Betaject. During the same period patient was treated with AZATIOPRIN (1 Tablet / Day) (View Azatioprin Review and Azatioprin Label ), CARBAMAZEPINE (4 Tablets / Day) (View Carbamazepine Review and Carbamazepine Label ), IBUPROFENO (View Ibuprofeno Review and Ibuprofeno Label ). Patient was hospitalized and became disabled.

6910651-8 | Burning Sensation, Eye Pain, Face Injury, Fall, Gait Disturbance, Headache, Malaise, Muscle Spasticity, Muscular Weakness
on Jul 27, 2010 Male patient from BRAZIL , 33 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?), headache (What is headache?) and was treated with Betaferon (View Usage). Patient experienced the following unwanted or unexpected effects: burning sensation, eye pain, face injury, fall (What is fall?), gait disturbance, headache (What is headache?), malaise, muscle spasticity, muscular weakness. Betaferon dosage: Betaject. During the same period patient was treated with AZATHIOPRINE (1 Tab A Day) (View Azathioprine Review and Azathioprine Label ), IBUPROFEN TABLETS (View Ibuprofen Tablets Review and Ibuprofen Tablets Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6895440-5 | Back Pain, Fatigue, Feeling Cold, Headache, Malaise, Neck Pain, Oropharyngeal Discomfort, Rash, Skin Warm
Patient was taking Betaferon (View Usage). Patient had the following side effects: back pain (What is back pain?), fatigue, feeling cold, headache (What is headache?), malaise, neck pain, oropharyngeal discomfort, rash (What is rash?), skin warm on Jul 16, 2010 from AUSTRALIA Additional patient health information: Female patient , 53 years of age, weighting 105.8 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Betaferon dosage: .

6895439-9 | Arthralgia, Back Pain, Bone Pain, Dizziness, Feeling Hot, Gait Disturbance, Headache, Hypoaesthesia, Impatience
Adverse event was reported on Jul 16, 2010 by a Female patient taking Betaferon (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: BRAZIL , 37 years of age, After Betaferon was administered, patient had the following side effects: arthralgia, back pain (What is back pain?), bone pain, dizziness (What is dizziness?), feeling hot, gait disturbance, headache (What is headache?), hypoaesthesia, impatience.

6895438-7 | Arthralgia, Balance Disorder, Constipation, Diplopia, Dizziness, Dysphonia, Eye Movement Disorder, Fall, Gait Disturbance
on Jul 21, 2010 Female patient from BRAZIL , 21 years of age, was diagnosed with relapsing-remitting multiple sclerosis, depression (What is depression?), insomnia, therapeutic procedure and was treated with Betaferon (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, balance disorder, constipation (What is constipation?), diplopia, dizziness (What is dizziness?), dysphonia, eye movement disorder, fall (What is fall?), gait disturbance. Betaferon dosage: Betaject. During the same period patient was treated with CLONAZEPAM (Total Daily Dose: 0.5 Mg Unit Dose: 0.5 Mg) (View Clonazepam Review and Clonazepam Label ), AMITRIPTYLINE HYDROCHLORIDE (Total Daily Dose: 25 Mg Unit Dose: 25 Mg) (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ), AMYTRIL (Total Daily Dose: 75 Mg Unit Dose: 75 Mg) (View Amytril Review and Amytril Label ), ALBENDAZOLE (As Used: 3 Df) (View Albendazole Review and Albendazole Label ). Patient was hospitalized.

6895437-5 | Adverse Event, Food Poisoning, Injection Site Haematoma, Injection Site Reaction, Mobility Decreased
on Jul 21, 2010 Male patient from UNITED KINGDOM , 56 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Betaferon (View Usage). Patient had the following side effects: adverse event, food poisoning, injection site haematoma, injection site reaction, mobility decreased. Betaferon dosage: . Patient was hospitalized and became disabled.

6895435-1 | Dehydration, Vomiting
Patient was taking Betaferon (View Usage). After Betaferon was administered, patient had the following side effects: dehydration, vomiting on Jul 15, 2010 from AUSTRALIA Additional patient health information: Female patient , 54 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Betaferon dosage: . During the same period patient was treated with AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6895432-6 | Delirium, Feeling Cold, Injection Site Erythema, Injection Site Mass, Injection Site Pain, Pyrexia
Adverse event was reported on Jul 21, 2010 by a Male patient taking Betaferon (View Usage) (Dosage: Started Use Betaject On 05-jun-2008) was diagnosed with multiple sclerosis (What is multiple sclerosis?), prophylaxis and. Location: BRAZIL , 27 years of age, Patient experienced the following unwanted or unexpected effects: delirium, feeling cold, injection site erythema, injection site mass, injection site pain, pyrexia. During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ).

6887642-9 | Major Depression, Multiple Sclerosis Relapse, Panniculitis, Thrombosis
on Jul 14, 2010 Female patient from SOUTH AFRICA , 43 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Betaferon (View Usage). Patient had the following side effects: major depression, multiple sclerosis relapse, panniculitis, thrombosis. Betaferon dosage: . Patient was hospitalized.

6887635-1 | Cellulitis, Impaired Healing, Induration, Inflammation, Injection Site Dryness, Injection Site Pruritus, Procedural Site Reaction
on Jul 14, 2010 Male patient from GERMANY , 57 years of age, weighting 132.3 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Betaferon (View Usage). After Betaferon was administered, patient had the following side effects: cellulitis (What is cellulitis?), impaired healing, induration, inflammation, injection site dryness, injection site pruritus, procedural site reaction. Betaferon dosage: . Patient was hospitalized.

6887614-4 | Pain In Extremity, Rash Macular
Patient was taking Betaferon (View Usage). Patient experienced the following unwanted or unexpected effects: pain in extremity, rash macular on Jul 20, 2010 from BRAZIL Additional patient health information: Female patient , 49 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?), anxiety (What is anxiety?), balance disorder, hypertension and. Betaferon dosage: Betaject. During the same period patient was treated with ETNA (1 Tablet) (View Etna Review and Etna Label ), BETASERC (1 Tablet) (View Betaserc Review and Betaserc Label ), CAPTOPRIL (Total Daily Dose: 50 Mg) (View Captopril Review and Captopril Label ).

6887612-0 | Mobility Decreased, Multiple Sclerosis Relapse
Adverse event was reported on Jul 20, 2010 by a Female patient taking Betaferon (View Usage) (Dosage: Total Daily Dose: 1 Ml) was diagnosed with multiple sclerosis (What is multiple sclerosis?), muscle spasms, depression (What is depression?) and. Location: BRAZIL , 31 years of age, Patient had the following side effects: mobility decreased, multiple sclerosis relapse. During the same period patient was treated with BACLOFEN (View Baclofen Review and Baclofen Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ). Patient was hospitalized and became disabled.

6887610-7 | Atrophy
on Jul 14, 2010 Female patient from BRAZIL , 39 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Betaferon (View Usage). After Betaferon was administered, patient had the following side effects: atrophy. Betaferon dosage: . During the same period patient was treated with AMITRIPTYLINE HYDROCHLORIDE (As Used: 3 Df) (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ), LORAZEPAM (Total Daily Dose: 1 Df) (View Lorazepam Review and Lorazepam Label ).

6887607-7 | Hyperhidrosis, Injection Site Haematoma, Injection Site Rash, Pain, Pyrexia, Syncope
on Jul 20, 2010 Female patient from BRAZIL , 38 years of age, was diagnosed with relapsing-remitting multiple sclerosis, oral contraception and was treated with Betaferon (View Usage). Patient experienced the following unwanted or unexpected effects: hyperhidrosis, injection site haematoma, injection site rash, pain (What is pain?), pyrexia, syncope. Betaferon dosage: Total Daily Dose: 0.75 Ml. During the same period patient was treated with SELENE (Total Daily Dose: 1 Df) (View Selene Review and Selene Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6880741-7 | Arthralgia, Back Pain, Bone Pain, Dizziness, Feeling Hot, Gait Disturbance, Headache, Hypoaesthesia, Impatience
Patient was taking Betaferon (View Usage). Patient had the following side effects: arthralgia, back pain (What is back pain?), bone pain, dizziness (What is dizziness?), feeling hot, gait disturbance, headache (What is headache?), hypoaesthesia, impatience on Jul 16, 2010 from BRAZIL Additional patient health information: Female patient , 37 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Betaferon dosage: .

6880738-7 | Abortion Missed, Asthenia, Body Temperature Increased, Decreased Appetite, High Risk Pregnancy, Menstruation Delayed, Viral Infection
Adverse event was reported on Jul 16, 2010 by a Female patient taking Betaferon (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: RUSSIAN FEDERATION , 26 years of age, After Betaferon was administered, patient had the following side effects: abortion missed, asthenia, body temperature increased, decreased appetite, high risk pregnancy, menstruation delayed, viral infection (What is viral infection?).

6880736-3 | Back Pain, Fatigue, Feeling Cold, Headache, Malaise, Neck Pain, Oropharyngeal Discomfort, Rash, Skin Warm
on Jul 16, 2010 Female patient from AUSTRALIA , 53 years of age, weighting 105.8 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Betaferon (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), fatigue, feeling cold, headache (What is headache?), malaise, neck pain, oropharyngeal discomfort, rash (What is rash?), skin warm. Betaferon dosage: .

6879143-9 | Abdominal Pain, Arthralgia, Decreased Appetite, Diarrhoea, Headache, Hyperhidrosis, Influenza, Injection Site Erythema, Injection Site Pain
on Jul 15, 2010 Female patient from BRAZIL , 32 years of age, was diagnosed with progressive multiple sclerosis, headache (What is headache?) and was treated with Betaferon (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), arthralgia, decreased appetite, diarrhoea, headache (What is headache?), hyperhidrosis, influenza, injection site erythema, injection site pain. Betaferon dosage: Total Daily Dose: 8 Miu. During the same period patient was treated with CLONAZEPAM (Total Daily Dose: 2 Mg Unit Dose: 2 Mg) (View Clonazepam Review and Clonazepam Label ), TYLEX (Total Daily Dose: 30 Mg Unit Dose: 30 Mg) (View Tylex Review and Tylex Label ), AMITRIPTYLINE HCL (As Used: 25 Mg Unit Dose: 25 Mg) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), TOPAMAX (Total Daily Dose: 50 Mg Unit Dose: 50 Mg) (View Topamax Review and Topamax Label ).

6879130-0 | Fall, Head Injury
Patient was taking Betaferon (View Usage). After Betaferon was administered, patient had the following side effects: fall (What is fall?), head injury on Jul 09, 2010 from AUSTRALIA Additional patient health information: Female patient , 72 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?), cystitis and. Betaferon dosage: . During the same period patient was treated with CYMBALTA (View Cymbalta Review and Cymbalta Label ), DITROPAN (View Ditropan Review and Ditropan Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), EPILEM (View Epilem Review and Epilem Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6879015-X | Dehydration, Vomiting
Adverse event was reported on Jul 15, 2010 by a Female patient taking Betaferon (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: AUSTRALIA , 54 years of age, Patient experienced the following unwanted or unexpected effects: dehydration, vomiting. During the same period patient was treated with AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6878762-3 | Cellulitis, Impaired Healing, Induration, Inflammation, Injection Site Dryness, Injection Site Pruritus, Procedural Site Reaction
on Jul 14, 2010 Male patient from GERMANY , 57 years of age, weighting 132.3 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Betaferon (View Usage). Patient had the following side effects: cellulitis (What is cellulitis?), impaired healing, induration, inflammation, injection site dryness, injection site pruritus, procedural site reaction. Betaferon dosage: . Patient was hospitalized.

6878757-X | Atrophy
on Jul 14, 2010 Female patient from BRAZIL , 39 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Betaferon (View Usage). After Betaferon was administered, patient had the following side effects: atrophy. Betaferon dosage: . During the same period patient was treated with AMITRIPTYLINE HYDROCHLORIDE (As Used: 3 Df) (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ), LORAZEPAM (Total Daily Dose: 1 Df) (View Lorazepam Review and Lorazepam Label ).

6878756-8 | Major Depression, Multiple Sclerosis Relapse, Panniculitis, Thrombosis
Patient was taking Betaferon (View Usage). Patient experienced the following unwanted or unexpected effects: major depression, multiple sclerosis relapse, panniculitis, thrombosis on Jul 14, 2010 from SOUTH AFRICA Additional patient health information: Female patient , 43 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Betaferon dosage: . Patient was hospitalized.

6862001-3 | Fall, Head Injury
Adverse event was reported on Jul 09, 2010 by a Female patient taking Betaferon (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?), cystitis and. Location: AUSTRALIA , 72 years of age, Patient had the following side effects: fall (What is fall?), head injury. During the same period patient was treated with CYMBALTA (View Cymbalta Review and Cymbalta Label ), DITROPAN (View Ditropan Review and Ditropan Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), EPILEM (View Epilem Review and Epilem Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6847371-4 | Headache, Hemiparesis, Injection Site Discolouration, Injection Site Pain, Injection Site Rash, Insomnia, Menstrual Disorder, Mobility Decreased
on Jul 12, 2010 Female patient from BRAZIL , 27 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?), pyrexia, contraception and was treated with Betaferon (View Usage). After Betaferon was administered, patient had the following side effects: headache (What is headache?), hemiparesis, injection site discolouration, injection site pain, injection site rash, insomnia, menstrual disorder, mobility decreased. Betaferon dosage: Betaject.

6844712-9 | Adverse Event, Injection Site Haematoma, Injection Site Reaction, Mobility Decreased
on Jun 30, 2010 Male patient from UNITED KINGDOM , 56 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Betaferon (View Usage). Patient experienced the following unwanted or unexpected effects: adverse event, injection site haematoma, injection site reaction, mobility decreased. Betaferon dosage: . Patient was hospitalized and became disabled.

6844710-5 | Rheumatic Fever, Systemic Lupus Erythematosus
Patient was taking Betaferon (View Usage). Patient had the following side effects: rheumatic fever, systemic lupus erythematosus on Jul 08, 2010 from FRANCE Additional patient health information: Female patient , 63 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Betaferon dosage: .